GLIMICEF M1
GLIMICEF M1 is combination antidiabetic medications used to manage type 2 diabetes mellitus. The combination includes Glimepiride, a sulfonylurea that stimulates insulin release from the pancreas, and Metformin Hydrochloride (Extended-Release), a biguanide that improves insulin sensitivity and reduces hepatic glucose production. This combination is effective in controlling blood glucose levels in patients who require more than one medication to achieve glycemic control.
| SKU: | 002 |
| category: | vitamins |
| tags: | suppliments |
Composition
Each tablet contains:
| Glimepiride: | 1 mg |
| Metformin Hydrochloride (Extended-Release): | 500 mg |
Formulation: Oral solid dosage in the form of extended-release (ER) tablets designed for prolonged, steady
release of medication over time.
Effective Glycemic Control: The combination of Glimepiride and Metformin offers synergistic
effects for better blood glucose control, targeting both insulin resistance and insulin secretion.
Convenience: Combining two antidiabetic agents in a single tablet improves patient compliance
and simplifies the treatment regimen.
Reduction in HbA1c: Regular use can lead to significant reductions in HbA1c levels, helping to
lower the risk of diabetes-related complications.
Extended-Release Formulation: The Metformin component is in extended-release form,
ensuring a steady release of the medication over time, improving tolerability and reducing
gastrointestinal side effects.
Weight Management: Metformin is known to have a neutral effect on weight, and in some
cases, it may assist in weight loss, which is beneficial for diabetic patients.
Metabolic disorder, Low blood sugar, Vitamin B12 deficiency